Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
Department of Pediatric Endocrinology, Wilhelmina Children's Hospital, 3584 EA Utrecht, The Netherlands.
J Clin Endocrinol Metab. 2022 Nov 23;107(11):3035-3044. doi: 10.1210/clinem/dgac516.
The purpose of this study is to report development of a malignant testicular germ cell tumor (GCT) in 2 young adult males with familial male-limited precocious puberty (FMPP) because of LHCGR pathogenic variants in 2 families. Secondarily, to study the possible relation between FMPP and testicular tumors and to investigate whether FMPP might predispose to development of malignant testicular tumors in adulthood a literature review is conducted.
Data on 6 cases in 2 families are obtained from the available medical records. In addition, a database search is performed in Cochrane, PubMed, and Embase for studies that report on a possible link between FMPP and testicular tumors.
The characteristics of 6 males with FMPP based on activating LH receptor (LHCGR) germline pathogenic variants are described, as are details of the testicular GCTs. Furthermore, a literature review identified 4 more patients with signs of FMPP and a (precursor of) testicular GCT in adolescence or adulthood (age 15-35 years). Additionally, 12 patients with signs of precocious puberty and, simultaneously, occurrence of a Leydig cell adenoma or Leydig cell hyperplasia are reported.
There is a strong suggestion that FMPP might increase the risk of development of testicular GCTs in early adulthood compared with the risk in the general population. Therefore, prolonged patient monitoring from mid-pubertal age onward including instruction for self-examination and periodic testicular ultrasound investigation in patients with a germline LHCGR pathogenic variant might contribute to early detection and thus early treatment of testicular GCT.
本研究旨在报告 2 个家族中因 LHCGR 致病变异导致家族性男性限性性早熟(FMPP)的 2 名年轻成年男性发生恶性睾丸生殖细胞肿瘤(GCT)的情况。其次,研究 FMPP 与睾丸肿瘤之间的可能关系,并探讨 FMPP 是否可能使成年后发生恶性睾丸肿瘤的风险增加。为此进行了文献复习。
从现有的病历中获取了 2 个家族中 6 例患者的数据。此外,还在 Cochrane、PubMed 和 Embase 数据库中进行了检索,以寻找报告 FMPP 与睾丸肿瘤之间可能存在关联的研究。
描述了 6 例基于激活黄体生成素受体(LHCGR)种系致病变异的具有 FMPP 特征的男性的特征,以及睾丸 GCT 的详细情况。此外,文献复习还确定了另外 4 例在青少年或成年期(15-35 岁)出现 FMPP 和(睾丸 GCT 的前兆)的患者。此外,还报告了 12 例表现为性早熟且同时发生间质细胞瘤腺瘤或间质细胞瘤增生的患者。
强烈提示 FMPP 可能使成年早期发生睾丸 GCT 的风险高于普通人群。因此,从中度青春期开始对患者进行长期监测,包括对具有种系 LHCGR 致病变异的患者进行自我检查和定期睾丸超声检查,可能有助于早期发现和早期治疗睾丸 GCT。